Clinical Trials Browser

Phase 2/3 × Unknown × Trastuzumab × Clear all

NCT05189067 2022-01-12

Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer

Phase 2/3 Unknown

HER2-positive Breast Cancer

NCT03085368 2017-07-28

A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin

Phase 2/3 Unknown

Breast Neoplasms